Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Item No. 36278

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
γ-D-Glutamylglycine (γ-DGG) is an antagonist of the excitatory amino acids NMDA (Item No. 14581), quisqualate, kainate, and glutamate.1 It decreases the amplitude of excitatory post-synaptic potentials (EPSPs) in electrically stimulated rat hippocampal slices when used at a concentration of 200 mM. Subdural administration of γ-DGG inhibits NMDA-, kainate-, or quisqualate-induced paw biting, indicating antinociceptive activity, in mice (EC50s = 63, 9.5, and 31 µM, respectively).2 γ-DGG reduces sound-induced wild running and inhibits the clonic and tonic phases of sound-induced seizures in DBA/2 mice (ED50s = 0.058, 0.046, and 0.054 µmol, i.c.v., respectively).3
WARNING This product is not for human or veterinary use.
1. Blockade of amino acid-
2. Spinal antinociceptive effects of excitatory amino acid antagonists: Quisqualate modulates the action of N-
3. Anticonvulsant action of excitatory amino acid antagonists. Science 216(4548), 899-901 (1982).